Terrence Chew
Corporate Officer/Principal at ImmuneWorks, Inc.
Profile
Terrence Chew is currently the Head-Clinical & Regulatory Development at ImmuneWorks, Inc. He previously worked as the Director-Medical Research at Agouron Pharmaceuticals LLC, Principal at Johnson & Johnson, Vice President-Regulatory & Clinical Affairs at Avid Bioservices, Inc., and Vice President-Clinical Development at DepoTech Corp.
He also served as the Chief Medical Officer at Prescient Therapeutics Ltd.
from 2015 to 2020.
Dr. Chew holds a doctorate degree from the University of California, Los Angeles and an undergraduate degree from the University of California, Berkeley.
Terrence Chew active positions
| Companies | Position | Start |
|---|---|---|
ImmuneWorks, Inc.
 ImmuneWorks, Inc. BiotechnologyHealth Technology ImmuneWorks, Inc. develops autoimmune lung diseases treatment. It offers therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. The company was founded by David S. Wilkes, Ronald L. Meeusen, and Michael J. Klemsz in January 2006 and is headquartered Indianapolis, IN. | Corporate Officer/Principal | - |
Former positions of Terrence Chew
| Companies | Position | End |
|---|---|---|
| PRESCIENT THERAPEUTICS LIMITED | Chief Tech/Sci/R&D Officer | 2020-06-30 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
DepoTech Corp.
 DepoTech Corp. Medical SpecialtiesHealth Technology DepoTech, Inc. developed and manufactured sustained-release therapeutic products based on DepoFoam, an injectable drug-delivery technology. It's products are developed to treat major medical needs in fields such as cancer, infectious diseases, pain management and rheumatology. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| AVID BIOSERVICES, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Terrence Chew
| University of California, Berkeley | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AVID BIOSERVICES, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| PRESCIENT THERAPEUTICS LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
ImmuneWorks, Inc.
ImmuneWorks, Inc. BiotechnologyHealth Technology ImmuneWorks, Inc. develops autoimmune lung diseases treatment. It offers therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. The company was founded by David S. Wilkes, Ronald L. Meeusen, and Michael J. Klemsz in January 2006 and is headquartered Indianapolis, IN. | Health Technology |
DepoTech Corp.
DepoTech Corp. Medical SpecialtiesHealth Technology DepoTech, Inc. developed and manufactured sustained-release therapeutic products based on DepoFoam, an injectable drug-delivery technology. It's products are developed to treat major medical needs in fields such as cancer, infectious diseases, pain management and rheumatology. The company was headquartered in San Diego, CA. | Health Technology |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Terrence Chew
